Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 73, Issue 5, Pages S23-S26Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2015.07.047
Keywords
clinical subtypes; hidradenitis suppurativa; Hurley staging; inflammatory; noninflammatory; Physician Global Assessment; Sartorius score; severity
Categories
Funding
- AbbVie Corporation
Ask authors/readers for more resources
Current classifications for hidradenitis suppurativa (HS), such as the Hurley staging system, are not very specific. The absence of rigorous classifications is incongruous with the clinical variability of the condition. There is no pathognomonic sign for HS that leads to a diagnosis that is unquestionable. Consequently, diagnosis is made largely through clinical presentation of the condition. The use of several validated tools assists in confirming the diagnosis and the severity of the disease. In future investigations, the identification of phenotypes and clinical subtypes-taking into account genetic variants-will serve to identify subpopulations of patients who are responsive to particular therapies, thereby improving the overall therapeutic picture for patients with HS. There is a potential for personalized, tailored delivery of therapy in the HS setting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available